FDA — authorised 27 September 2006
- Application: ANDA077250
- Marketing authorisation holder: SEPTODONT
- Local brand name: VIVACAINE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Bupivacaine alone in United States
FDA authorised Bupivacaine alone on 27 September 2006
Marketing authorisation
Other Anesthesia approved in United States
Frequently asked questions
Is Bupivacaine alone approved in United States?
Yes. FDA authorised it on 27 September 2006.
Who is the marketing authorisation holder for Bupivacaine alone in United States?
SEPTODONT holds the US marketing authorisation.